> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Outsourcing Facility Fees
- URL: https://www.fdaweb.com/guide-on-outsourcing-facility-fees-2/
- Published: 2017-10-16T12:00:00.000Z
- Updated: 2026-09-14T22:56:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139881

*Federal Register* notice: FDA has sent to OMB an information collection extension request for a guidance on “Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act.” The guidance was mandated by the 2013 Drug Quality and Security Act that established drug compounding “outsourcing facilities” that, once registered, must pay certain fees outlined in the guidance. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-10-16/pdf/2017-22283.pdf?ref=fdaweb.com).